IBDEI268 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,36829,0)
 ;;=J64.^^137^1772^11
 ;;^UTILITY(U,$J,358.3,36829,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36829,1,3,0)
 ;;=3^Pneumoconiosis,Unspec
 ;;^UTILITY(U,$J,358.3,36829,1,4,0)
 ;;=4^J64.
 ;;^UTILITY(U,$J,358.3,36829,2)
 ;;=^5008271
 ;;^UTILITY(U,$J,358.3,36830,0)
 ;;=G89.22^^137^1773^2
 ;;^UTILITY(U,$J,358.3,36830,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36830,1,3,0)
 ;;=3^Chr Post-Thoracotomy Pain
 ;;^UTILITY(U,$J,358.3,36830,1,4,0)
 ;;=4^G89.22
 ;;^UTILITY(U,$J,358.3,36830,2)
 ;;=^5004156
 ;;^UTILITY(U,$J,358.3,36831,0)
 ;;=G89.3^^137^1773^3
 ;;^UTILITY(U,$J,358.3,36831,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36831,1,3,0)
 ;;=3^Neoplasm Related Pain
 ;;^UTILITY(U,$J,358.3,36831,1,4,0)
 ;;=4^G89.3
 ;;^UTILITY(U,$J,358.3,36831,2)
 ;;=^5004159
 ;;^UTILITY(U,$J,358.3,36832,0)
 ;;=G89.18^^137^1773^1
 ;;^UTILITY(U,$J,358.3,36832,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36832,1,3,0)
 ;;=3^Acute Postprocedural Pain
 ;;^UTILITY(U,$J,358.3,36832,1,4,0)
 ;;=4^G89.18
 ;;^UTILITY(U,$J,358.3,36832,2)
 ;;=^5004154
 ;;^UTILITY(U,$J,358.3,36833,0)
 ;;=J94.1^^137^1774^1
 ;;^UTILITY(U,$J,358.3,36833,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36833,1,3,0)
 ;;=3^Fibrothorax
 ;;^UTILITY(U,$J,358.3,36833,1,4,0)
 ;;=4^J94.1
 ;;^UTILITY(U,$J,358.3,36833,2)
 ;;=^5008317
 ;;^UTILITY(U,$J,358.3,36834,0)
 ;;=C45.0^^137^1774^2
 ;;^UTILITY(U,$J,358.3,36834,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36834,1,3,0)
 ;;=3^Pleura Mesothelioma
 ;;^UTILITY(U,$J,358.3,36834,1,4,0)
 ;;=4^C45.0
 ;;^UTILITY(U,$J,358.3,36834,2)
 ;;=^5001095
 ;;^UTILITY(U,$J,358.3,36835,0)
 ;;=J94.8^^137^1774^4
 ;;^UTILITY(U,$J,358.3,36835,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36835,1,3,0)
 ;;=3^Pleural Conditions NEC
 ;;^UTILITY(U,$J,358.3,36835,1,4,0)
 ;;=4^J94.8
 ;;^UTILITY(U,$J,358.3,36835,2)
 ;;=^5008319
 ;;^UTILITY(U,$J,358.3,36836,0)
 ;;=J94.9^^137^1774^3
 ;;^UTILITY(U,$J,358.3,36836,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36836,1,3,0)
 ;;=3^Pleural Condition,Unspec
 ;;^UTILITY(U,$J,358.3,36836,1,4,0)
 ;;=4^J94.9
 ;;^UTILITY(U,$J,358.3,36836,2)
 ;;=^5008320
 ;;^UTILITY(U,$J,358.3,36837,0)
 ;;=J91.8^^137^1774^6
 ;;^UTILITY(U,$J,358.3,36837,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36837,1,3,0)
 ;;=3^Pleural Effusion in Conditions Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,36837,1,4,0)
 ;;=4^J91.8
 ;;^UTILITY(U,$J,358.3,36837,2)
 ;;=^5008311
 ;;^UTILITY(U,$J,358.3,36838,0)
 ;;=J90.^^137^1774^5
 ;;^UTILITY(U,$J,358.3,36838,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36838,1,3,0)
 ;;=3^Pleural Effusion NEC
 ;;^UTILITY(U,$J,358.3,36838,1,4,0)
 ;;=4^J90.
 ;;^UTILITY(U,$J,358.3,36838,2)
 ;;=^5008310
 ;;^UTILITY(U,$J,358.3,36839,0)
 ;;=J92.0^^137^1774^7
 ;;^UTILITY(U,$J,358.3,36839,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36839,1,3,0)
 ;;=3^Pleural Plaque w/ Presence of Asbestos
 ;;^UTILITY(U,$J,358.3,36839,1,4,0)
 ;;=4^J92.0
 ;;^UTILITY(U,$J,358.3,36839,2)
 ;;=^5008312
 ;;^UTILITY(U,$J,358.3,36840,0)
 ;;=J92.9^^137^1774^8
 ;;^UTILITY(U,$J,358.3,36840,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36840,1,3,0)
 ;;=3^Pleural Plaque w/o Asbestos
 ;;^UTILITY(U,$J,358.3,36840,1,4,0)
 ;;=4^J92.9
 ;;^UTILITY(U,$J,358.3,36840,2)
 ;;=^5008313
 ;;^UTILITY(U,$J,358.3,36841,0)
 ;;=R09.1^^137^1774^9
 ;;^UTILITY(U,$J,358.3,36841,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36841,1,3,0)
 ;;=3^Pleurisy
 ;;^UTILITY(U,$J,358.3,36841,1,4,0)
 ;;=4^R09.1
 ;;^UTILITY(U,$J,358.3,36841,2)
 ;;=^95428
 ;;^UTILITY(U,$J,358.3,36842,0)
 ;;=J86.0^^137^1774^10
 ;;^UTILITY(U,$J,358.3,36842,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36842,1,3,0)
 ;;=3^Pyothorax w/ Fistula
